Answers are grounded in this paper and cite their sources.
Rosacea is a chronic inflammatory dermatosis characterized by burning, stinging and heat sensitivity. However, the involvement of the primary somatosensory cortex (S1) in rosacea remains poorly understood. To determine whether the primary somatosensory cortex (S1) contributes to rosacea-like inflammation and to evaluate its potential as a therapeutic target. We assessed S1 ALFF and ReHo using resting-state fMRI in patients with rosacea. In mice, we used cutaneous pseudorabies virus (PRV) tracing, c-Fos staining, chemogenetic activation and inhibition, quantitative skin proteomics and resiniferatoxin (RTX) treatment to investigate S1 involvement in LL37-induced rosacea-like inflammation. The effects of S1 activation and inhibition were further examined in an imiquimod-induced psoriasiform dermatitis model. Inhibitory repetitive transcranial magnetic stimulation (rTMS) targeting S1 was evaluated in both models. Skin-directed PRV tracing labelled neurons in S1, suggesting neural connectivity between the skin and S1. S1 c-Fos expression increased following noxious cutaneous stimuli and during LL37-induced rosacea-like inflammation. Resting-state fMRI suggested reduced right S1 ReHo and ALFF in rosacea patients with higher disease burden. Chemogenetic manipulation further established the causal role of S1 in modulating cutaneous inflammation. S1 activation exacerbated LL37-induced rosacea-like dermatitis, as evidenced by increased erythema, skin thickness, inflammatory cell infiltration, cytokine expression, and CD4 + T-cell accumulation, whereas S1 inhibition attenuated these responses. S1 activation alone was insufficient to induce dermatitis, indicating that S1 amplifies peripheral inflammation rather than initiating disease. Sensory denervation with RTX reduced inflammation-induced S1 activation and mitigated S1-driven disease aggravation, accompanied by decreased expression of activating transcription factor 3 (ATF3) in dorsal root ganglia (DRG). Similar effects of S1 manipulation were observed in imiquimod-induced psoriasiform dermatitis. Inhibitory rTMS targeting S1 effectively alleviated skin inflammation in mouse models of both rosacea and psoriasis. These findings identify S1 as an amplifier of rosacea-associated inflammation and support S1-targeted neuromodulation as a potential treatment for rosacea.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: